Circulating lipocalin-2 and features of metabolic syndrome in community-dwelling older women: A cross-sectional study

Lipocalin-2 (LCN2) is released by several cell types including osteoblasts and adipocytes and has been suggested as a marker of renal dysfunction, metabolic syndrome (MetS) and type 2 diabetes (T2D). Whether LCN2 is linked to these diseases in older women remains unknown. This study investigated whe...

Full description

Saved in:
Bibliographic Details
Published in:Bone (New York, N.Y.) N.Y.), 2023-11, Vol.176, p.116861-116861, Article 116861
Main Authors: Bauer, Carlie, Sim, Marc, Prince, Richard L., Zhu, Kun, Lim, Ee M., Byrnes, Elizabeth, Pavlos, Nathan, Lim, Wai H., Wong, Germaine, Lewis, Joshua R., Levinger, Itamar
Format: Article
Language:English
Subjects:
Aging
Bone-muscle-fat interactions
Human association studies
Metabolism
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c351t-28d5c35e1dcc1c709a7fd0b47aff0ab35f680ddac4b9b8386866a81ef4aaa1b23
container_end_page 116861
container_issue
container_start_page 116861
container_title Bone (New York, N.Y.)
container_volume 176
creator Bauer, Carlie
Sim, Marc
Prince, Richard L.
Zhu, Kun
Lim, Ee M.
Byrnes, Elizabeth
Pavlos, Nathan
Lim, Wai H.
Wong, Germaine
Lewis, Joshua R.
Levinger, Itamar
description Lipocalin-2 (LCN2) is released by several cell types including osteoblasts and adipocytes and has been suggested as a marker of renal dysfunction, metabolic syndrome (MetS) and type 2 diabetes (T2D). Whether LCN2 is linked to these diseases in older women remains unknown. This study investigated whether LCN2 is related to features of MetS and T2D in older women. This cross-sectional study included 705 non-diabetic women (mean age 75.1 ± 2.6 years) for MetS analysis and 76 women (mean age 75.4 ± 2.8 years) with T2D. Total circulating LCN2 levels were analysed using a two-step chemiluminescent microparticle monoclonal immunoassay. MetS was determined by a modified National Cholesterol Education Program Adult Treatment Panel III classification. Multivariable-adjusted logistic regression analysis was used to assess odds ratios between LCN2 quartiles and MetS. Women in the highest LCN2 quartile had approximately 3 times greater risk for MetS compared to women in the lowest quartile (OR 3.05; 95%CI 1.86–5.02). Women with T2D or MetS scores of ≥ 3 had higher LCN2 levels compared to women with a MetS score of 0 (p 
doi_str_mv 10.1016/j.bone.2023.116861
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2844679587</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S8756328223001941</els_id><sourcerecordid>2844679587</sourcerecordid><originalsourceid>FETCH-LOGICAL-c351t-28d5c35e1dcc1c709a7fd0b47aff0ab35f680ddac4b9b8386866a81ef4aaa1b23</originalsourceid><addsrcrecordid>eNp9kD1v2zAQhomiQeM6-QMdCo5Z5PJDEqmgS2D0CwiQJZkJijwGNCjSIaUG_veh4zRjp7vhfR_cPQh9oWRDCe2_7TZjirBhhPENpb3s6Qe0olLwhomef0QrKbq-4Uyyc_S5lB0hhA-CfkLnXHSsZQNfoWXrs1mCnn18xMHvk9HBx4ZhHS12oOclQ8HJ4QlmPabgDS6HaHOaAPuITZqmJfr50NhnCOEIScFCxs81EK_xDTY5ldIUMLNPUQdc5sUeLtCZ06HA5dtco4efP-63v5vbu19_tje3jeEdnRsmbVc3oNYYagQZtHCWjK3QzhE98s71klirTTsOo-SyKui1pOBarTUdGV-jqxN3n9PTAmVWky-mHqojpKUoJtu2F0NXna0RO0VfD87g1D77SeeDokQddaudOupWR93qpLuWvr7xl3EC-17557cGvp8CUL_86yGrYjxEA9bnqkTZ5P_HfwGHfZO9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2844679587</pqid></control><display><type>article</type><title>Circulating lipocalin-2 and features of metabolic syndrome in community-dwelling older women: A cross-sectional study</title><source>ScienceDirect Journals</source><creator>Bauer, Carlie ; Sim, Marc ; Prince, Richard L. ; Zhu, Kun ; Lim, Ee M. ; Byrnes, Elizabeth ; Pavlos, Nathan ; Lim, Wai H. ; Wong, Germaine ; Lewis, Joshua R. ; Levinger, Itamar</creator><creatorcontrib>Bauer, Carlie ; Sim, Marc ; Prince, Richard L. ; Zhu, Kun ; Lim, Ee M. ; Byrnes, Elizabeth ; Pavlos, Nathan ; Lim, Wai H. ; Wong, Germaine ; Lewis, Joshua R. ; Levinger, Itamar</creatorcontrib><description>Lipocalin-2 (LCN2) is released by several cell types including osteoblasts and adipocytes and has been suggested as a marker of renal dysfunction, metabolic syndrome (MetS) and type 2 diabetes (T2D). Whether LCN2 is linked to these diseases in older women remains unknown. This study investigated whether LCN2 is related to features of MetS and T2D in older women. This cross-sectional study included 705 non-diabetic women (mean age 75.1 ± 2.6 years) for MetS analysis and 76 women (mean age 75.4 ± 2.8 years) with T2D. Total circulating LCN2 levels were analysed using a two-step chemiluminescent microparticle monoclonal immunoassay. MetS was determined by a modified National Cholesterol Education Program Adult Treatment Panel III classification. Multivariable-adjusted logistic regression analysis was used to assess odds ratios between LCN2 quartiles and MetS. Women in the highest LCN2 quartile had approximately 3 times greater risk for MetS compared to women in the lowest quartile (OR 3.05; 95%CI 1.86–5.02). Women with T2D or MetS scores of ≥ 3 had higher LCN2 levels compared to women with a MetS score of 0 (p &lt; 0.05). Higher LCN2 correlated with higher body mass index, fat mass, triglycerides and glycated haemoglobin and lower high-density lipoprotein cholesterol and estimated glomerular filtration rate (p &lt; 0.05). Higher circulating levels of LCN2 are associated with worsened cardio-metabolic risk factors and increased odds of MetS and T2D in older women. Whether it can be used as a biomarker for identifying those at risk for MetS and T2D should be explored further. •Women in the highest quartile of LCN2 had ~3 times greater odds for MetS compared to women in the lowest quartile.•Women without T2D in the highest LCN2 quartile had higher LCN2 compared to those with T2D.•LCN2 may be a useful biomarker for identifying women at risk of MetS.</description><identifier>ISSN: 8756-3282</identifier><identifier>EISSN: 1873-2763</identifier><identifier>DOI: 10.1016/j.bone.2023.116861</identifier><identifier>PMID: 37524293</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aging ; Bone-muscle-fat interactions ; Human association studies ; Metabolism</subject><ispartof>Bone (New York, N.Y.), 2023-11, Vol.176, p.116861-116861, Article 116861</ispartof><rights>2023 The Authors</rights><rights>Copyright © 2023. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c351t-28d5c35e1dcc1c709a7fd0b47aff0ab35f680ddac4b9b8386866a81ef4aaa1b23</cites><orcidid>0000-0001-9194-2033</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37524293$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bauer, Carlie</creatorcontrib><creatorcontrib>Sim, Marc</creatorcontrib><creatorcontrib>Prince, Richard L.</creatorcontrib><creatorcontrib>Zhu, Kun</creatorcontrib><creatorcontrib>Lim, Ee M.</creatorcontrib><creatorcontrib>Byrnes, Elizabeth</creatorcontrib><creatorcontrib>Pavlos, Nathan</creatorcontrib><creatorcontrib>Lim, Wai H.</creatorcontrib><creatorcontrib>Wong, Germaine</creatorcontrib><creatorcontrib>Lewis, Joshua R.</creatorcontrib><creatorcontrib>Levinger, Itamar</creatorcontrib><title>Circulating lipocalin-2 and features of metabolic syndrome in community-dwelling older women: A cross-sectional study</title><title>Bone (New York, N.Y.)</title><addtitle>Bone</addtitle><description>Lipocalin-2 (LCN2) is released by several cell types including osteoblasts and adipocytes and has been suggested as a marker of renal dysfunction, metabolic syndrome (MetS) and type 2 diabetes (T2D). Whether LCN2 is linked to these diseases in older women remains unknown. This study investigated whether LCN2 is related to features of MetS and T2D in older women. This cross-sectional study included 705 non-diabetic women (mean age 75.1 ± 2.6 years) for MetS analysis and 76 women (mean age 75.4 ± 2.8 years) with T2D. Total circulating LCN2 levels were analysed using a two-step chemiluminescent microparticle monoclonal immunoassay. MetS was determined by a modified National Cholesterol Education Program Adult Treatment Panel III classification. Multivariable-adjusted logistic regression analysis was used to assess odds ratios between LCN2 quartiles and MetS. Women in the highest LCN2 quartile had approximately 3 times greater risk for MetS compared to women in the lowest quartile (OR 3.05; 95%CI 1.86–5.02). Women with T2D or MetS scores of ≥ 3 had higher LCN2 levels compared to women with a MetS score of 0 (p &lt; 0.05). Higher LCN2 correlated with higher body mass index, fat mass, triglycerides and glycated haemoglobin and lower high-density lipoprotein cholesterol and estimated glomerular filtration rate (p &lt; 0.05). Higher circulating levels of LCN2 are associated with worsened cardio-metabolic risk factors and increased odds of MetS and T2D in older women. Whether it can be used as a biomarker for identifying those at risk for MetS and T2D should be explored further. •Women in the highest quartile of LCN2 had ~3 times greater odds for MetS compared to women in the lowest quartile.•Women without T2D in the highest LCN2 quartile had higher LCN2 compared to those with T2D.•LCN2 may be a useful biomarker for identifying women at risk of MetS.</description><subject>Aging</subject><subject>Bone-muscle-fat interactions</subject><subject>Human association studies</subject><subject>Metabolism</subject><issn>8756-3282</issn><issn>1873-2763</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kD1v2zAQhomiQeM6-QMdCo5Z5PJDEqmgS2D0CwiQJZkJijwGNCjSIaUG_veh4zRjp7vhfR_cPQh9oWRDCe2_7TZjirBhhPENpb3s6Qe0olLwhomef0QrKbq-4Uyyc_S5lB0hhA-CfkLnXHSsZQNfoWXrs1mCnn18xMHvk9HBx4ZhHS12oOclQ8HJ4QlmPabgDS6HaHOaAPuITZqmJfr50NhnCOEIScFCxs81EK_xDTY5ldIUMLNPUQdc5sUeLtCZ06HA5dtco4efP-63v5vbu19_tje3jeEdnRsmbVc3oNYYagQZtHCWjK3QzhE98s71klirTTsOo-SyKui1pOBarTUdGV-jqxN3n9PTAmVWky-mHqojpKUoJtu2F0NXna0RO0VfD87g1D77SeeDokQddaudOupWR93qpLuWvr7xl3EC-17557cGvp8CUL_86yGrYjxEA9bnqkTZ5P_HfwGHfZO9</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>Bauer, Carlie</creator><creator>Sim, Marc</creator><creator>Prince, Richard L.</creator><creator>Zhu, Kun</creator><creator>Lim, Ee M.</creator><creator>Byrnes, Elizabeth</creator><creator>Pavlos, Nathan</creator><creator>Lim, Wai H.</creator><creator>Wong, Germaine</creator><creator>Lewis, Joshua R.</creator><creator>Levinger, Itamar</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9194-2033</orcidid></search><sort><creationdate>20231101</creationdate><title>Circulating lipocalin-2 and features of metabolic syndrome in community-dwelling older women: A cross-sectional study</title><author>Bauer, Carlie ; Sim, Marc ; Prince, Richard L. ; Zhu, Kun ; Lim, Ee M. ; Byrnes, Elizabeth ; Pavlos, Nathan ; Lim, Wai H. ; Wong, Germaine ; Lewis, Joshua R. ; Levinger, Itamar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c351t-28d5c35e1dcc1c709a7fd0b47aff0ab35f680ddac4b9b8386866a81ef4aaa1b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Aging</topic><topic>Bone-muscle-fat interactions</topic><topic>Human association studies</topic><topic>Metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bauer, Carlie</creatorcontrib><creatorcontrib>Sim, Marc</creatorcontrib><creatorcontrib>Prince, Richard L.</creatorcontrib><creatorcontrib>Zhu, Kun</creatorcontrib><creatorcontrib>Lim, Ee M.</creatorcontrib><creatorcontrib>Byrnes, Elizabeth</creatorcontrib><creatorcontrib>Pavlos, Nathan</creatorcontrib><creatorcontrib>Lim, Wai H.</creatorcontrib><creatorcontrib>Wong, Germaine</creatorcontrib><creatorcontrib>Lewis, Joshua R.</creatorcontrib><creatorcontrib>Levinger, Itamar</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bone (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bauer, Carlie</au><au>Sim, Marc</au><au>Prince, Richard L.</au><au>Zhu, Kun</au><au>Lim, Ee M.</au><au>Byrnes, Elizabeth</au><au>Pavlos, Nathan</au><au>Lim, Wai H.</au><au>Wong, Germaine</au><au>Lewis, Joshua R.</au><au>Levinger, Itamar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Circulating lipocalin-2 and features of metabolic syndrome in community-dwelling older women: A cross-sectional study</atitle><jtitle>Bone (New York, N.Y.)</jtitle><addtitle>Bone</addtitle><date>2023-11-01</date><risdate>2023</risdate><volume>176</volume><spage>116861</spage><epage>116861</epage><pages>116861-116861</pages><artnum>116861</artnum><issn>8756-3282</issn><eissn>1873-2763</eissn><abstract>Lipocalin-2 (LCN2) is released by several cell types including osteoblasts and adipocytes and has been suggested as a marker of renal dysfunction, metabolic syndrome (MetS) and type 2 diabetes (T2D). Whether LCN2 is linked to these diseases in older women remains unknown. This study investigated whether LCN2 is related to features of MetS and T2D in older women. This cross-sectional study included 705 non-diabetic women (mean age 75.1 ± 2.6 years) for MetS analysis and 76 women (mean age 75.4 ± 2.8 years) with T2D. Total circulating LCN2 levels were analysed using a two-step chemiluminescent microparticle monoclonal immunoassay. MetS was determined by a modified National Cholesterol Education Program Adult Treatment Panel III classification. Multivariable-adjusted logistic regression analysis was used to assess odds ratios between LCN2 quartiles and MetS. Women in the highest LCN2 quartile had approximately 3 times greater risk for MetS compared to women in the lowest quartile (OR 3.05; 95%CI 1.86–5.02). Women with T2D or MetS scores of ≥ 3 had higher LCN2 levels compared to women with a MetS score of 0 (p &lt; 0.05). Higher LCN2 correlated with higher body mass index, fat mass, triglycerides and glycated haemoglobin and lower high-density lipoprotein cholesterol and estimated glomerular filtration rate (p &lt; 0.05). Higher circulating levels of LCN2 are associated with worsened cardio-metabolic risk factors and increased odds of MetS and T2D in older women. Whether it can be used as a biomarker for identifying those at risk for MetS and T2D should be explored further. •Women in the highest quartile of LCN2 had ~3 times greater odds for MetS compared to women in the lowest quartile.•Women without T2D in the highest LCN2 quartile had higher LCN2 compared to those with T2D.•LCN2 may be a useful biomarker for identifying women at risk of MetS.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>37524293</pmid><doi>10.1016/j.bone.2023.116861</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-9194-2033</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 8756-3282
ispartof Bone (New York, N.Y.), 2023-11, Vol.176, p.116861-116861, Article 116861
issn 8756-3282
1873-2763
language eng
recordid cdi_proquest_miscellaneous_2844679587
source ScienceDirect Journals
subjects Aging
Bone-muscle-fat interactions
Human association studies
Metabolism
title Circulating lipocalin-2 and features of metabolic syndrome in community-dwelling older women: A cross-sectional study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T20%3A00%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Circulating%20lipocalin-2%20and%20features%20of%20metabolic%20syndrome%20in%20community-dwelling%20older%20women:%20A%20cross-sectional%20study&rft.jtitle=Bone%20(New%20York,%20N.Y.)&rft.au=Bauer,%20Carlie&rft.date=2023-11-01&rft.volume=176&rft.spage=116861&rft.epage=116861&rft.pages=116861-116861&rft.artnum=116861&rft.issn=8756-3282&rft.eissn=1873-2763&rft_id=info:doi/10.1016/j.bone.2023.116861&rft_dat=%3Cproquest_cross%3E2844679587%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c351t-28d5c35e1dcc1c709a7fd0b47aff0ab35f680ddac4b9b8386866a81ef4aaa1b23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2844679587&rft_id=info:pmid/37524293&rfr_iscdi=true